PHAT 最新季度财报
公布日期10/29/2026
实际每股收益(美元)-0.16
实际营收(美元)84.72M
本页面提供详细的 Phathom Pharmaceuticals Inc 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Phathom Pharmaceuticals Inc 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 10/29/2026 | 09/2026 | -0.16/-0.14 | 84.72M/85.18M | -17.98% | -0.54% |
| 7/30/2026 | 06/2026 | -0.21/-0.25 | 74.27M/72.79M | 16.50% | 2.04% |
| 4/30/2026 | 03/2026 | -0.37/-0.32 | 58.30M/57.03M | -14.90% | 2.23% |
| 2/26/2026 | 12/2025 | -0.29/-0.38 | 57.58M/57.05M | 24.90% | 0.94% |
| 10/30/2025 | 09/2025 | -0.41/-0.55 | 49.50M/46.99M | 25.07% | 5.34% |
| 8/7/2025 | 06/2025 | -1.05/-1.04 | 39.50M/36.08M | -0.59% | 9.50% |
| 5/1/2025 | 03/2025 | -1.31/-1.15 | 28.52M/29.02M | -14.29% | -1.71% |
| 3/6/2025 | 12/2024 | -1.05/-1.27 | 29.66M/24.91M | 17.63% | 19.09% |
Phathom Pharmaceuticals (PHAT) 2026年第三季度业绩电话会议: 营收增长71%, 重申业绩指引